Molnupiravir for moisture-proof packaging of drugs two requirements

 Molnupiravir is an antiviral drug that inhibits the replication of certain RNA viruses. For the treatment of COVID-19 in people infected with SARS-CoV-2. It belongs to a small molecule drug and is in the form of capsules. What are the requirements of this drug for moisture-proof packaging of drugs?

50ml desiccant bottle

40ml desiccant bottle

medicine cap

Capsules refer to capsules made of special film-forming materials (such as gelatin, cellulose, polysaccharides, etc.), into which the contents (such as powdered and liquid medicines, etc.) or doses are loaded for easy swallowing. Medicines in capsules are generally powders or granules that are irritating to the esophagus and gastric mucosa, or have bad taste, are easily volatile, are easily decomposed by saliva in the oral cavity, and are easily inhaled into the trachea. These medicines are packed into capsules, which not only protect the medicinal properties of the medicines from being destroyed, but also protect the digestive organs and respiratory tract. Removing the capsule shell may result in drug loss, drug waste, and reduced efficacy. In addition, some drugs need to be dissolved and absorbed in the intestine, and the capsule protects the drug from being destroyed by stomach acid.

Molnupiravir's requirements for moisture-proof packaging of pharmaceuticals are mainly moisture-proof and airtight. These drugs are very sensitive to water molecules, and are prone to adhesion and deliquescence after being exposed to moisture, and their efficacy is greatly reduced, and sometimes there are toxic and side effects. In order to maintain the stability of the internal environment of the packaging, a desiccant will be included in the moisture-proof packaging of medicines to absorb moisture. There are also strict requirements for indicators such as the water absorption rate of the desiccant. In terms of sealing, it is mainly the ability of the bottle mouth and the bottle cap to cooperate, and to ensure the accuracy of the size, in order to better ensure the good sealing of the package.

The above are the two requirements of Molnupiravir for moisture-proof packaging of drugs, which are also two very important aspects to maintain drug stability and safety. Pharmaceutical companies should pay attention when choosing packaging.

DMF List

How does Molnupiravir bottle prevent moisture

 Molnupiravir was jointly developed by Merck and Ridgeback for the treatment of COVID-19 in patients infected with SARS-CoV-2, and has received emergency approvals in India, the United Kingdom, the United States and other places. This drug is a capsule preparation. As a special dosage form, how can its drug packaging be moisture-proof?

Capsule preparation is a capsule made of special film-forming materials (such as gelatin, cellulose, polysaccharide, etc.), into which the contents (such as powder, liquid drugs, etc.) or doses are loaded. This drug is very sensitive to water molecules, and it is easy to stick and deliquescence after being wet, which affects the efficacy of the drug. The pharmaceutical packaging used for this drug must have very good moisture resistance.

50ml pharma deiccant bottle

75ml child resistant bottle

Medicinal plastic bottle is a commonly used packaging method for capsule preparations. In order to prevent the drug from getting wet, a desiccant will be placed in the moisture-proof packaging of the drug, which can absorb the water molecules inside the package and maintain the stability of the internal environment. The desiccant is mainly based on silica gel and molecular sieve, or a mixture of the two in equal proportions. The silica gel desiccant can effectively control the number of water molecules for a long time. effect.

The desiccant in the moisture-proof packaging of medicines is mostly packaged in bags. With the continuous evolution of packaging, packaging with more novel functions has gradually appeared. A small medicine warehouse is designed on the bottle cap to store the desiccant, which can prevent Direct contact between the drug and the desiccant can also prevent children from accidentally eating the desiccant. This novel design of packaging also increases the added value of drugs and becomes the choice of more and more pharmaceutical companies.

Molnupiravir for moisture-proof packaging of drugs two requirements

Molnupiravir is an antiviral drug that inhibits the replication of certain RNA viruses. For the treatment of COVID-19 in people infected with SARS-CoV-2. It belongs to a small molecule drug and is in the form of capsules. What are the requirements of this drug for moisture-proof packaging of drugs?

50ml desiccant bottle

40ml desiccant bottle

medicine cap

Capsules refer to capsules made of special film-forming materials (such as gelatin, cellulose, polysaccharides, etc.), into which the contents (such as powdered and liquid medicines, etc.) or doses are loaded for easy swallowing. Medicines in capsules are generally powders or granules that are irritating to the esophagus and gastric mucosa, or have bad taste, are easily volatile, are easily decomposed by saliva in the oral cavity, and are easily inhaled into the trachea. These medicines are packed into capsules, which not only protect the medicinal properties of the medicines from being destroyed, but also protect the digestive organs and respiratory tract. Removing the capsule shell may result in drug loss, drug waste, and reduced efficacy. In addition, some drugs need to be dissolved and absorbed in the intestine, and the capsule protects the drug from being destroyed by stomach acid.

Molnupiravir's requirements for moisture-proof packaging of pharmaceuticals are mainly moisture-proof and airtight. These drugs are very sensitive to water molecules, and are prone to adhesion and deliquescence after being exposed to moisture, and their efficacy is greatly reduced, and sometimes there are toxic and side effects. In order to maintain the stability of the internal environment of the packaging, a desiccant will be included in the moisture-proof packaging of medicines to absorb moisture. There are also strict requirements for indicators such as the water absorption rate of the desiccant. In terms of sealing, it is mainly the ability of the bottle mouth and the bottle cap to cooperate, and to ensure the accuracy of the size, in order to better ensure the good sealing of the package.

The above are the two requirements of Molnupiravir for moisture-proof packaging of drugs, which are also two very important aspects to maintain drug stability and safety. Pharmaceutical companies should pay attention when choosing packaging.

DMF List